Search

This article examines the outcomes of patients with Caesarean scar pregnancy (CSP) who were symptomatic at the time of diagnosis compared to those who were asymptomatic. The study found that symptomatic patients were less likely to have a successful CSP compared to asymptomatic patients. However, there were no significant differences in the rate of therapeutic interventions or the time it took for complete resolution between the two groups. The study also noted that symptomatic patients were more likely to be of Hispanic race. Overall, this research suggests that being symptomatic at the time of CSP diagnosis may increase the likelihood of a failed CSP, but further investigation is needed. [Extracted from the article]

This article, titled "Transvaginal ultrasound-guided feticide in the management of interstitial ectopic pregnancy," discusses the effectiveness and safety of using transvaginal ultrasound-guided feticide as a treatment for interstitial ectopic pregnancy (IEP). The study, conducted at a New York City academic institution between 2010 and 2023, included 23 patients with IEP. The primary outcome of the study was treatment success, defined as resolution without surgical intervention. The results showed that transvaginal ultrasound-guided feticide was highly effective and safe for managing live IEPs, with minimal complications. [Extracted from the article]

This article discusses the efficacy and safety of minimally invasive approaches in the treatment of cervical ectopic pregnancy (CEP). The study analyzed cases of CEP at a New York City medical center from 2010 to 2023. The primary treatment options included transvaginal ultrasound-guided feticide, transcervical balloon catheter insertion, and systemic methotrexate (MTX). The results showed that both transvaginal ultrasound-guided feticide and transcervical balloon catheter were effective in resolving live CEP without surgical intervention. Systemic MTX was used for non-live CEP cases, with some requiring additional interventions. Overall, the study suggests that minimally invasive management can successfully treat CEP. [Extracted from the article]

This article discusses the outcomes of expectant management in cases of live Caesarean scar pregnancies (CSP). The study, conducted at a New York City tertiary academic institution between 2010 and 2023, found that among 110 CSP diagnoses, 70 were viable and 19 patients chose expectant management. The average gestational age at diagnosis was 9.2 weeks. While expectant management presented considerable maternal risk, with a high rate of hysterectomy, three-quarters of patients achieved a live birth, albeit preterm. The study emphasizes the importance of rigorous clinical decision-making and patient education regarding the associated risks. [Extracted from the article]